PCT/2000/51 - World Intellectual Property Organization
PCT/2000/51 - World Intellectual Property Organization
PCT/2000/51 - World Intellectual Property Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>51</strong>/<strong>2000</strong><br />
19142 <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 21 Dec/déc <strong>2000</strong><br />
20882 (US). KOMATSOULIS, George,<br />
A. [US/US]; 9<strong>51</strong>8 Garwood Street, Silver<br />
Spring, MD 20901 (US).<br />
(74) HOOVER, Kenley, K. et al. / etc.; Human<br />
Genome Sciences, Inc., 9410 Key West Avenue,<br />
Rockville, MD 20850 (US).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CR CU CZ DE DK DM EE ES FI<br />
GB GD GE GH GM HR HU ID IL IN IS JP<br />
KE KG KP KR KZ LC LK LR LS LT LU LV<br />
MA MD MG MK MN MW MX NO NZ PL<br />
PT RO RU SD SE SG SI SK SL TJ TM TR<br />
TT TZ UA UG US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
Published / Publiée :(c)<br />
(<strong>51</strong>) 7 C12N 15/12, C07K 14/435, A61K 38/17,<br />
G01N 33/50, C12Q 1/68, C07K 16/18,<br />
C12N 5/20<br />
(11) WO 00/77198 (13) A2<br />
(21) <strong>PCT</strong>/BE00/00061<br />
(22) 6 Jun/juin <strong>2000</strong> (06.06.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 9913425.6 9 Jun/juin 1999 GB<br />
(09.06.1999)<br />
(43) 21 Dec/déc <strong>2000</strong> (21.12.<strong>2000</strong>)<br />
(54) IDENTIFICATION AND MOLECULAR<br />
CHARACTERISATION OF PROTEINS,<br />
EXPRESSED IN THE TICK SALIVARY<br />
GLANDS<br />
IDENTIFICATION ET CARACTERISA-<br />
TION MOLECULAIRE DE PROTEINES<br />
EXPRIMEES DANS LES GLANDES SA-<br />
LIVAIRES DE LA TIQUE<br />
(71) HENOGEN S.A. [BE/BE]; Rue des Prof.<br />
Jeener et Brachet 12, B-6041 Gosselies (BE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) GODFROID, Edmond [BE/BE]; Avenue<br />
de l’Araucaria 13, B-1020 Brussels<br />
(BE). BOLLEN, Alex [BE/BE]; Gaasbeekstraat<br />
65, B-1701 Itterbeek (BE).<br />
LEBOULLE, Gérard [BE/BE]; Rue Rodenbach<br />
108, B-1190 Brussels (BE).<br />
(74) DE KEMMETER, François; Cabinet Bede<br />
S.A., Place de l’Alma 3, B-1200 Brussels<br />
(BE).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID IL<br />
IN IS JP KE KG KP KR KZ LC LK LR LS<br />
LT LU LV MA MD MG MK MN MW MX<br />
MZ NO NZ PL PT RO RU SD SE SG SI SK<br />
SL TJ TM TR TT TZ UA UG US UZ VN YU<br />
ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(<strong>51</strong>) 7 C12N 15/12, 5/10, C07K 14/705, 16/28,<br />
A61K 38/17, G01N 33/50<br />
(11) WO 00/77199 (13) A1<br />
(21) <strong>PCT</strong>/EP00/05592<br />
(22) 14 Jun/juin <strong>2000</strong> (14.06.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 9913850.5 14 Jun/juin 1999 GB<br />
(14.06.1999)<br />
(43) 21 Dec/déc <strong>2000</strong> (21.12.<strong>2000</strong>)<br />
(54) CLONING AND EXPRESSION OF A<br />
NOVEL 5-HT4 RECEPTOR<br />
CLONAGE ET EXPRESSION D’UN<br />
NOUVEAU RECEPTEUR 5-HT4<br />
(71) JANSSEN PHARMACEUTICA N.V.<br />
[BE/BE]; Turnhoutseweg 30, B-2340 Beerse<br />
(BE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) BENDER, Eckhard [DE/BE]; Janssen<br />
Pharmaceutica N.V., Turnhoutseweg 30,<br />
B-2340 Beerse (BE). PINDON, Armelle,<br />
Nathalie [FR/BE]; Janssen Pharmaceutica<br />
N.V., Turnhoutseweg 30, B-2340 Beerse<br />
(BE). VAN OERS, Irma, Petronella<br />
[NL/BE]; Janssen Pharmaceutica N.V.,<br />
Turnhoutseweg 30, B-2340 Beerse (BE).<br />
JURZAK, Mirek [DE/BE]; Janssen Pharmaceutica<br />
N.V., Turnhoutseweg 30, B-2340<br />
Beerse (BE). LUYTEN, Walter, Herman,<br />
Maria, Louis [BE/BE]; Janssen Pharmaceutica<br />
N.V., Turnhoutseweg 30, B-2340 Beerse<br />
(BE).<br />
(74) BALDOCK, Sharon, Claire; Boult Wade<br />
Tennant, Verulam Gardens, 70 Gray’s Inn<br />
Road, London WC1X 8BT (GB).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID IL<br />
IN IS JP KE KG KP KR KZ LC LK LR LS<br />
LT LU LV MA MD MG MK MN MW MX<br />
MZ NO NZ PL PT RO RU SD SE SG SI SK<br />
SL TJ TM TR TT TZ UA UG US UZ VN YU<br />
ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
Published / Publiée :(c)<br />
(<strong>51</strong>) 7 C12N 15/12, 15/11, C07K 14/47, A61K<br />
38/17, G01N 33/53, 33/68, C12Q 1/68<br />
(11) WO 00/77200 (13) A1<br />
(21) <strong>PCT</strong>/GB00/02177<br />
(22) 6 Jun/juin <strong>2000</strong> (06.06.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 09/329,418 10 Jun/juin 1999 US<br />
(10.06.1999)<br />
(43) 21 Dec/déc <strong>2000</strong> (21.12.<strong>2000</strong>)<br />
(54) RECEPTOR INTERACTING PROTEIN<br />
RIP3<br />
PROTEINE RIP3 INTERAGISSANT<br />
SUR DES RECEPTEURS<br />
(71) ASTRAZENECA AB [SE/SE]; S-1<strong>51</strong> 85<br />
Sodertalje (SE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf MG)<br />
(71) ASTRAZENECA UK LIMITED<br />
[GB/GB]; 15 Stanhope Gate, London W1Y<br />
6LN (GB).<br />
(only for / seulement pour MG)<br />
(72) GOMES, Bruce, Charles; 1800 Concord<br />
Pike, Wilmington, DE 19850-5437 (US).<br />
KASOF, Garrett, Mitchell; 1800 Concord<br />
Pike, Wilmington, DE 19850-5437 (US).<br />
PROSSER, Judith, Caroline; 1800 Concord<br />
Pike, Wilmington, DE 19850-5437 (US).<br />
(74) GAINEY, Laurence, David, Scott; AstraZeneca,<br />
P.O. Box 272, Mereside, Alderley<br />
Park, Macclesfield, Cheshire SK10 4TG<br />
(GB).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID IL<br />
IN IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MA MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ<br />
TM TR TT TZ UA UG UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(<strong>51</strong>) 7 C12N 15/12, C07K 14/47, 16/18, C12Q<br />
1/68, C12N 15/11, A61K 38/17<br />
(11) WO 00/77201<br />
(21) <strong>PCT</strong>/GB00/02272<br />
(13) A1<br />
(22) 9 Jun/juin <strong>2000</strong> (09.06.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 60/139,291 15 Jun/juin 1999<br />
(15.06.1999)<br />
US<br />
(43) 21 Dec/déc <strong>2000</strong> (21.12.<strong>2000</strong>)<br />
(54) LIVIN; INHIBITOR-OF-APOPTOSIS<br />
PROTEIN-3 (IAP-3)<br />
PROTEINE-3 INHIBITEUR D’APOP-<br />
TOSE (IAP-3), DESIGNEE SOUS LE<br />
NOM DE LIVINE<br />
(71) ASTRAZENECA AB [SE/SE]; S-1<strong>51</strong> 85<br />
Soderjalje (SE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf MG)<br />
(71) ASTRAZENECA UK LIMITED<br />
[GB/GB]; 15 Stanhope Gate, London W1Y<br />
6LN (GB).<br />
(only for / seulement pour MG)<br />
(72) GOMES, Bruce, Charles; 1800 Concord<br />
Pike, Wilmington, DE 19850-5437 (US).<br />
KASOF, Garrett, Mitchell; 1800 Concord<br />
Pike, Wilmington, DE 19850-5437 (US).<br />
PROSSER, Judith, Caroline; 1800 Concord<br />
Pike, Wilmington, DE 19850-5437 (US).<br />
(74) GAINEY, Laurence, David, Scott; Astrazeneca,<br />
Global <strong>Intellectual</strong> <strong>Property</strong>, P.O.<br />
Box 272, Mereside, Alderley Park, Macclesfield,<br />
Cheshire SK10 4GR (GB).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID IL<br />
IN IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MA MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ<br />
TM TR TT TZ UA UG UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).
Change language